Asthma Clinical Trial
— ESMAAOfficial title:
Evaluation of aSthma Management in Middle EAst Adult Population
| Verified date | November 2016 |
| Source | AstraZeneca |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Algeria: Ministry of Health |
| Study type | Observational |
Descriptive study on the management of asthma in asthmatic Middle East adult population : Algeria,Egypt, Irak,Iran, Jordan, Koweit, Lebanon, Qatar,Saudi,Tunisia, UAE
| Status | Completed |
| Enrollment | 7294 |
| Est. completion date | December 2015 |
| Est. primary completion date | December 2015 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years to 130 Years |
| Eligibility |
Inclusion Criteria: Men and women, 18 years of age and older. Asthmatic since at least one year before inclusion. Patient's informed consent obtained. Exclusion Criteria: - Patient concurrently participating to another study. Patient with concomitant pulmonary disease. Patient with psychiatric disorders. Patient consulting for an asthma attack |
Observational Model: Case-Only, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| Algeria | Research Site | Ain Beida | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Ain Naadja | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Alger | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Annaba | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Azzaba | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Bab el Oued | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Bab Ezzouar | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Babez | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Batna | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Bejaia | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Beni Messous | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Birkhadem | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Blida | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Bordj Bou Arreridj | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Bordj Menail | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Bouira | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Bouzareah | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Constantine | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | El Eulma | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Essania | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Gouraya | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Lakhdaria | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Larbaa | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Mascara | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Meftah | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Mila | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Misserghine | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Mostaghanem | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Msila | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Oran | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Rouiba | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Setif | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Sidi Bel Abbes | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Tiaret | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Tipaza | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Tizi Ouzou | Nis-rme-xxx-2014/1 |
| Algeria | Research Site | Zeralda | Nis-rme-xxx-2014/1 |
| Egypt | Research Site | Alexandria | Nis-rme-xxx-2014/1 |
| Egypt | Research Site | Cairo | Nis-rme-xxx-2014/1 |
| Egypt | Research Site | Domyat - Delta | Nis-rme-xxx-2014/1 |
| Egypt | Research Site | Giza - Cairo | Nis-rme-xxx-2014/1 |
| Egypt | Research Site | Ismalia - Delta | Nis-rme-xxx-2014/1 |
| Egypt | Research Site | Mansoura - Delta | Nis-rme-xxx-2014/1 |
| Egypt | Research Site | Menofia - Delta | Nis-rme-xxx-2014/1 |
| Egypt | Research Site | Menoufia - Delta | Nis-rme-xxx-2014/1 |
| Egypt | Research Site | Portsaid - Delta | Nis-rme-xxx-2014/1 |
| Egypt | Research Site | Tanta - Delta | Nis-rme-xxx-2014/1 |
| Egypt | Research Site | Zagazig - Delta | Nis-rme-xxx-2014/1 |
| Iran, Islamic Republic of | Research Site | Ahwaz | Nis-rme-xxx-2014/1 |
| Iran, Islamic Republic of | Research Site | Isfahan | Nis-rme-xxx-2014/1 |
| Iran, Islamic Republic of | Research Site | Karaj | Nis-rme-xxx-2014/1 |
| Iran, Islamic Republic of | Research Site | Kerman | Nis-rme-xxx-2014/1 |
| Iran, Islamic Republic of | Research Site | Mashhad | Nis-rme-xxx-2014/1 |
| Iran, Islamic Republic of | Research Site | Rasht | Nis-rme-xxx-2014/1 |
| Iran, Islamic Republic of | Research Site | Sari | Nis-rme-xxx-2014/1 |
| Iran, Islamic Republic of | Research Site | Shiraz | Nis-rme-xxx-2014/1 |
| Iran, Islamic Republic of | Research Site | Tabriz | Nis-rme-xxx-2014/1 |
| Iran, Islamic Republic of | Research Site | Tehran | Nis-rme-xxx-2014/1 |
| Iran, Islamic Republic of | Research Site | Yazd | Nis-rme-xxx-2014/1 |
| Iraq | Research Site | Baghdad | Nis-rme-xxx-2014/1 |
| Iraq | Research Site | Basra | Nis-rme-xxx-2014/1 |
| Iraq | Research Site | Erbil | Nis-rme-xxx-2014/1 |
| Iraq | Research Site | Hilla | Nis-rme-xxx-2014/1 |
| Iraq | Research Site | Najaf | Nis-rme-xxx-2014/1 |
| Iraq | Research Site | Nasria | Nis-rme-xxx-2014/1 |
| Iraq | Research Site | Sulaimania | Nis-rme-xxx-2014/1 |
| Jordan | Research Site | Al Salt | Nis-rme-xxx-2014/1 |
| Jordan | Research Site | Amman | Nis-rme-xxx-2014/1 |
| Jordan | Research Site | Irbid | Nis-rme-xxx-2014/1 |
| Jordan | Research Site | Madaba | Nis-rme-xxx-2014/1 |
| Jordan | Research Site | Rusaifa | Nis-rme-xxx-2014/1 |
| Jordan | Research Site | Zarqa | Nis-rme-xxx-2014/1 |
| Kuwait | Research Site | Kuwait | Nis-rme-xxx-2014/1 |
| Kuwait | Research Site | Kuwait | Nis-rme-xxx-2014/2 |
| Kuwait | Research Site | Kuwait | Nis-rme-xxx-2014/5 |
| Lebanon | Research Site | Bkaa | Nis-rme-xxx-2014/1 |
| Lebanon | Research Site | Chweifat | Nis-rme-xxx-2014/1 |
| Lebanon | Research Site | Dahieh | Nis-rme-xxx-2014/1 |
| Lebanon | Research Site | East Beirut | Nis-rme-xxx-2014/1 |
| Lebanon | Research Site | Keserwen | Nis-rme-xxx-2014/1 |
| Lebanon | Research Site | Maten | Nis-rme-xxx-2014/1 |
| Lebanon | Research Site | North Beirut | Nis-rme-xxx-2014/1 |
| Lebanon | Research Site | South Beirut | Nis-rme-xxx-2014/1 |
| Lebanon | Research Site | South Metn | Nis-rme-xxx-2014/1 |
| Lebanon | Research Site | West Beirut | Nis-rme-xxx-2014/1 |
| Qatar | Research Site | Doha | Nis-rme-xxx-2014/1 |
| Saudi Arabia | Research Site | Al Hada | Nis-rme-xxx-2014/1 |
| Saudi Arabia | Research Site | Al Khobar | Nis-rme-xxx-2014/1 |
| Saudi Arabia | Research Site | Dammam | Nis-rme-xxx-2014/1 |
| Saudi Arabia | Research Site | Jeddah | Nis-rme-xxx-2014/1 |
| Saudi Arabia | Research Site | Riyadh | Nis-rme-xxx-2014/1 |
| Tunisia | Research Site | Sfax | Nis-rme-xxx-2014/1 |
| Tunisia | Research Site | Sousse | Nis-rme-xxx-2014/1 |
| Tunisia | Research Site | Tunis | Nis-rme-xxx-2014/1 |
| United Arab Emirates | Research Site | Abu Dhabi | Nis-rme-xxx-2014/1 |
| United Arab Emirates | Research Site | Al Ain | Nis-rme-xxx-2014/1 |
| United Arab Emirates | Research Site | Dubai | Nis-rme-xxx-2014/1 |
| United Arab Emirates | Research Site | Sharjah | Nis-rme-xxx-2014/1 |
| Lead Sponsor | Collaborator |
|---|---|
| AstraZeneca |
Algeria, Egypt, Iran, Islamic Republic of, Iraq, Jordan, Kuwait, Lebanon, Qatar, Saudi Arabia, Tunisia, United Arab Emirates,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Asthma control | Daytime symptoms Limitation of activities Nocturnal symptoms / awakening Need for reliever /rescue treatment Lung function (PEF or FEV) | Up to 1 year | No |
| Secondary | general and sociodemographic patient's characteristics | sex, age, BMI, educational level, occupation, comorbidities, smoking status, and social security coverage. | up to 1 year | No |
| Secondary | Identify predictive factors of asthma control, | such as age, sex, BMI, smoking status, adherence to treatment, asthma history, comorbidity. | UP to 1 year | No |
| Secondary | asthma control level | Asthma control test questionnaire : activities at work,breathless,asthma symptoms (wheezing, coughing, chest tightness, shortness of breath;use of rescue inhaler or taken a nebulizer treatment ,asthma assessment | Up to 4 weeks | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|